Psoriatic Arthritis Treatment Market: AI-Driven Therapeutic Advances

Spread the love

Based on Fortune Business Insights’ report, the psoriatic arthritis treatment market share sector attained a worth of USD 6.35 billion in 2019. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 9.5% from 2019 to 2027. This trajectory will culminate in a noteworthy achievement of USD 13.12 billion by 2027, highlighting considerable opportunities within this flourishing high-volume industry. North America dominated the market in 2019.

Request a Free Sample PDF Brochure of Psoriatic Arthritis Treatment Market:

In a recent study, Fortune Business Insights presents the nitty-gritty of the global Psoriatic Arthritis Treatment Market considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities, and market growth trends. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.

Top Companies in the Psoriatic Arthritis Treatment Market:

  • Smith & Nephew (London, U.K.)
  • 3M (Minnesota, U.S)
  • Cardinal Health (Dublin, Ohio)
  • Talley Group Ltd (Romsey, U.K)
  • ConvaTec Inc. (England, U.K.)
  • DeRoyal Industries, Inc. (Powell, U.S)
  • Devon Medical Products (King of Prussia, U.S)
  • BSN medical (Hamburg, Germany)
  • Medela AG (Baar, Switzerland)
  • Other Players

The Psoriatic Arthritis Treatment Market study outlines the key regions of North America, Latin America, Europe, East Asia, and Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing, and gross margin.

Psoriatic Arthritis Treatment Market Dynamics:

  • Expanding Patient Pool: The psoriatic arthritis treatment market experiences growth due to the expanding patient pool, driven by increasing awareness, improved diagnostics, and a growing prevalence of psoriatic arthritis worldwide.
  • Advancements in Biologic Therapies: Continuous advancements in biologic therapies, including TNF inhibitors, IL-17 inhibitors, and IL-23 inhibitors, drive innovation in psoriatic arthritis treatment, offering improved efficacy, safety, and disease control for patients with moderate to severe disease.
  • Personalized Treatment Approaches: The market sees a shift towards personalized treatment approaches in psoriatic arthritis, driven by advances in biomarker research, pharmacogenomics, and patient stratification strategies, enabling tailored treatment regimens and improved therapeutic outcomes.
  • Combination Therapies: There is a growing interest in combination therapies for psoriatic arthritis, combining biologic agents with conventional DMARDs, targeted synthetic DMARDs, and non-pharmacological interventions to optimize disease control, minimize joint damage, and improve quality of life for patients.
  • Market Access and Affordability: Market access considerations, including pricing pressures, reimbursement policies, and patient access programs, influence treatment decisions and market dynamics within the psoriatic arthritis treatment market, shaping product development strategies and competitive positioning among industry players.

The insights for each vendor consist of:

  • Company profile
  • SWOT analysis
  • Main market information
  • Market share
  • Revenue, pricing, and gross margin

Crucial insights in the Psoriatic Arthritis Treatment Market research:

  1. Underlying macro- and microeconomic factors impacting the growth of the Psoriatic Arthritis Treatment Market.
  2. Basic overview of Psoriatic Arthritis Treatment Market, including market definition, classification, and applications.
  3. Scrutinization of each Psoriatic Arthritis Treatment Market player based on mergers & acquisitions, R&D projects, and product launches.
  4. Adoption trend of Psoriatic Arthritis Treatment Market across various industries.
  5. Important regions and countries offer lucrative opportunities to Psoriatic Arthritis Treatment Market stakeholders.

Important regions covered in the Psoriatic Arthritis Treatment Market report include:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Table of Contents:

  • Introduction
    • Research Scope
    • Customer Segmentation
    • Data Gathering Strategies
    • Key Definitions & Caveats
  • Executive Summary
  • Market Dynamics
    • Psoriatic Arthritis Treatment Market Drivers
    • Psoriatic Arthritis Treatment Market Restraints
    • Market Opportunities
  • Key Insights
    • Value Chain
    • Major M&A moves and game-changing partnerships.
    • Covid-19 Impact
  • Future of the Healthcare Industry
  • Competitive Landscape
  • Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • Psoriatic Arthritis Treatment Market Growth Size 2024
  • Strategies Adopted by Leading Players
  • Company Profiles (Overview, Financials, Products and Services, and Recent Developments)
  • Disclaimer

TOC Continued…!


  1. How big is the Psoriatic Arthritis Treatment Market?
  2. What factors are influencing the Psoriatic Arthritis Treatment Market growth in North America?
  3. Who are the key Psoriatic Arthritis Treatment Market players?

Contact us:


Leave a Reply

Your email address will not be published. Required fields are marked *